Published in Pflugers Arch on June 17, 2016
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60
Determination of lymphocyte division by flow cytometry. J Immunol Methods (1994) 11.48
The CD40 antigen and its ligand. Annu Rev Immunol (1994) 7.26
CD40-CD40 ligand. J Leukoc Biol (2000) 6.28
How cells handle cholesterol. Science (2000) 5.56
Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med (1994) 5.35
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70
Phospholipids and the origin of cationic gating charges in voltage sensors. Nature (2006) 3.99
Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods (2000) 3.89
International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev (2005) 3.50
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A (2006) 3.13
How does voltage open an ion channel? Annu Rev Cell Dev Biol (2006) 3.05
K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature (1984) 2.89
Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet (1993) 2.79
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54
Scanning the intracellular S6 activation gate in the shaker K+ channel. J Gen Physiol (2002) 2.23
Two separate interfaces between the voltage sensor and pore are required for the function of voltage-dependent K(+) channels. PLoS Biol (2009) 2.12
Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) Am J Med Genet (1997) 2.09
Ion channels in innate and adaptive immunity. Annu Rev Immunol (2015) 1.99
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet (2015) 1.98
Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res (2010) 1.88
Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet (2008) 1.78
Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron (1995) 1.56
Attenuation of channel kinetics and conductance by cholesterol: an interpretation using structural stress as a unifying concept. J Membr Biol (1995) 1.52
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1989) 1.44
Cholesterol and ion channels. Subcell Biochem (2010) 1.36
How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol (2013) 1.22
Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS). J Inherit Metab Dis (2007) 1.20
Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J Lipid Res (2003) 1.14
Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome. J Lipid Res (1995) 1.11
Cholesterol modifies the gating of Kv1.3 in human T lymphocytes. Pflugers Arch (2003) 1.09
A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J Lipid Res (2005) 1.06
Identification of a binding motif in the S5 helix that confers cholesterol sensitivity to the TRPV1 ion channel. J Biol Chem (2011) 1.05
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J Exp Med (2006) 1.05
Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome. Am J Med Genet A (2010) 1.05
Lipidomics reveals membrane lipid remodelling and release of potential lipid mediators during early stress responses in a murine melanoma cell line. Biochim Biophys Acta (2010) 1.04
Cholesterol depletion activates rapid internalization of submicron-sized acetylcholine receptor domains at the cell membrane. Mol Membr Biol (2007) 1.03
Determination of the allelic frequency in Smith-Lemli-Opitz syndrome by analysis of massively parallel sequencing data sets. Clin Genet (2014) 1.02
Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. J Lipid Res (2011) 0.99
7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim Biophys Acta (2012) 0.96
The Smith-Lemli-Opitz syndrome: a novel metabolic way of understanding developmental biology, embryogenesis, and dysmorphology. Clin Genet (2001) 0.96
Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol (2012) 0.96
Multiple cholesterol recognition/interaction amino acid consensus (CRAC) motifs in cytosolic C tail of Slo1 subunit determine cholesterol sensitivity of Ca2+- and voltage-gated K+ (BK) channels. J Biol Chem (2012) 0.94
Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases. Immunol Lett (2009) 0.93
A KCNQ1 V205M missense mutation causes a high rate of long QT syndrome in a First Nations community of northern British Columbia: a community-based approach to understanding the impact. Genet Med (2008) 0.90
Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression. J Lipid Res (2005) 0.90
Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome. Expert Opin Orphan Drugs (2015) 0.90
Cholesterol binding to ion channels. Front Physiol (2014) 0.89
Flow cytometric analysis of cell division by dilution of CFSE and related dyes. Curr Protoc Cytom (2013) 0.89
A patient with Smith-Lemli-Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement. Eur J Pediatr (2009) 0.86
Studies on the immunosuppressive properties of 7,25 dihydroxycholesterol--II. Effects on early steps of T-cell activation. Int J Immunopharmacol (1989) 0.86
Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome. J Lipid Res (1995) 0.85
Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome. Eur J Pediatr (2013) 0.84
Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders. Free Radic Res (2014) 0.84
Plasma membrane cholesterol as a regulator of human and rodent P2X7 receptor activation and sensitization. J Biol Chem (2014) 0.83
Comparison of the liquid-ordered bilayer phases containing cholesterol or 7-dehydrocholesterol in modeling Smith-Lemli-Opitz syndrome. J Lipid Res (2010) 0.82
The role of PSD-95 in the rearrangement of Kv1.3 channels to the immunological synapse. Pflugers Arch (2013) 0.82
Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome. Mol Genet Metab (2011) 0.80
Mutational spectrum of smith-lemli-opitz syndrome patients in hungary. Mol Syndromol (2012) 0.79
The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation. Immunol Lett (2016) 0.77
The effects of 7-dehydrocholesterol on the structural properties of membranes. Phys Biol (2011) 0.77
Fatal adenovirus type 7b infection in a child with Smith-Lemli-Opitz syndrome. J Med Virol (2001) 0.76
Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state. Cell Immunol (2013) 0.76
Selective antibody immune deficiency in a patient with Smith-Lemli-Opitz syndrome. J Inherit Metab Dis (2005) 0.76
Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience. Clin Chem Lab Med (2011) 0.76
A calorimetric and spectroscopic comparison of the effects of cholesterol and its immediate biosynthetic precursors 7-dehydrocholesterol and desmosterol on the thermotropic phase behavior and organization of dipalmitoylphosphatidylcholine bilayer membranes. Chem Phys Lipids (2015) 0.76
Birthday of a syndrome: 50 years anniversary of Smith-Lemli-Opitz Syndrome. Eur J Hum Genet (2014) 0.75